Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Evotec
(OTCPK:EVOTF)
Intraday
$10.18
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$10.18
0
[0.00%]
At close: Apr 24
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Evotec Stock (OTC:EVOTF)
Evotec Stock (OTC: EVOTF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, December 06, 2023
Evotec's Partner Zhejiang Jingxin Pharmaceutical Secures Approval From Chinese Medical Authority For Evotec's Insomnia Drug, EVT201
Benzinga Newsdesk
-
Dec 6, 2023, 2:04AM
Wednesday, July 05, 2023
Apple Loses Appeal Over 4G Patent Infringement In London Court, AI Can Drive TSMC's Revenue Rebound, Alibaba Conducts Strategic Review of Youku and Tudou Amidst Rivalry: Today's Top Stories
Vandana Singh
-
Jul 5, 2023, 9:23AM
Evotec Secures US Government Contract For Orthopoxvirus Antibody
Vandana Singh
-
Jul 5, 2023, 7:45AM
Thursday, March 16, 2023
Evotec Announced Progress Within Its Partnership With Bristol Myers Squibb Relating To Building A Molecular Glue-based Pipeline. Performance And Program-based Achievements Trigger $75M To Evotec
Benzinga Newsdesk
-
Mar 16, 2023, 4:40AM
Wednesday, September 21, 2022
Adapsyn Bioscience Inks Collaboration Pact With Evotec
Vandana Singh
-
Sep 21, 2022, 10:06AM
Tuesday, September 20, 2022
Evotec Biologics Awarded Up to $49.9M Contract from the U.S. Department of Defense Under Accelerated Antibodies Program
Charles Gross
-
Sep 20, 2022, 4:56AM
Wednesday, July 06, 2022
The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate
Vandana Singh
-
Jul 6, 2022, 9:14AM
Tuesday, June 14, 2022
Exscientia Reports Topline Data From EXS-21546 Phase 1a Study
Bill Haddad
-
Jun 14, 2022, 8:17AM
Friday, February 04, 2022
Why Are Evotec Shares Trading Lower On Friday?
Vandana Singh
-
Feb 4, 2022, 2:44PM
Tuesday, January 18, 2022
Evotec and Lilly Entered into Drug Discovery Collaboration in Metabolic Diseases; Evotec to Receive Undisclosed Upfront Payment Plus Up to $1B in Milestone Payments and Royalties
Charles Gross
-
Jan 18, 2022, 4:30AM
Tuesday, January 11, 2022
Evotec Announced Expansion of Neuroscience Collaboration with Bristol Myers Squibb to Include New Targeted Protein Degradation Approach
Charles Gross
-
Jan 11, 2022, 5:29AM
Wednesday, October 27, 2021
Germany Based Evotec Sets Terms For $576M US IPO
Vandana Singh
-
Oct 27, 2021, 1:10PM
Monday, October 11, 2021
Pasithea, Evotec Ink Drug Development Pact
Vandana Singh
-
Oct 11, 2021, 8:34AM
Friday, October 08, 2021
Evotec Expands Neuroscience Collaboration with Bristol Myers
Vandana Singh
-
Oct 8, 2021, 9:36AM
Thursday, September 02, 2021
Bristol Myers Exercises Option In-License Evotec's Neurodegenerative Candidate
Vandana Singh
-
Sep 2, 2021, 9:46AM
Monday, April 19, 2021
Kazia Therapeutics Announced Worldwide Exclusive Licensing Deal & Master Services Deal With Evotec SE
Charles Gross
-
Apr 19, 2021, 5:17AM
Monday, March 01, 2021
Evotec, Chinook Therapeutics Ink Development Pact For Chronic Kidney Diseases Therapies
Vandana Singh
-
Mar 1, 2021, 5:22AM
Thursday, August 20, 2020
CENTOGENE and Evotec Announced Expanded Collaboration Into Gaucher Disease
Charles Gross
-
Aug 20, 2020, 6:12AM
Tuesday, August 18, 2020
Evotec and Novo Nordisk Form Strategic Alliance to Develop Novel Therapies for Kidney Diseases; Evotec tol Receive Undisclosed Upfront Payment, Research Funding and Milestone Potential of More Than €150M Per Product. Tiered Royalties on Net Sales
Charles Gross
-
Aug 18, 2020, 5:27AM
Thursday, April 30, 2020
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1
Shanthi Rexaline
-
Apr 30, 2020, 7:19AM
Wednesday, June 05, 2019
Evote, Celgene Expand Ipsc Collaboration Including New Cell Type; Triggers $9M Payment ro Evotec
Charles Gross
-
Jun 5, 2019, 4:11AM
Tuesday, July 03, 2018
Evotec Confirm Closing Of Transaction With Sanofi To Accelerate Infectious Disease Research And Development
Benzinga
-
Jul 3, 2018, 4:09AM
Tuesday, May 22, 2018
Evotec, Celgene Announce Strategic Oncology Partnership
Benzinga
-
May 22, 2018, 3:49AM
Friday, August 07, 2015
US Stock Futures Drop; All Eyes On Jobs Report
Benzinga
-
Aug 7, 2015, 7:57AM
Sanofi, Evotec Announce Strategic Collaboration for Diabetes
Benzinga
-
Aug 7, 2015, 4:48AM
Tuesday, June 30, 2015
Evotec's Partner Roche Provides Initial Update from Phase IIb Trial in Alzheimer's Disease
Benzinga
-
Jun 30, 2015, 3:38PM
Thursday, March 19, 2015
Evotec Sanofi Sign Agreement for Major Multi-Component Strategic Alliance Vlaued @€250M
Benzinga
-
Mar 19, 2015, 9:29PM